GlassScriptPhysician profile
Lisa Affatato-Bradley
NPI 1285639724
$928.54
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $913 · 2022: $15.65.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $158.68 | 2019 | |
| Novo Nordisk INC | $132.09 | 2019-2022 | |
| Allergan, INC. | $76.27 | 2019 | |
| Amgen INC. | $67.78 | 2019 | |
| Lilly USA, LLC | $61.80 | 2019 | |
| Janssen Biotech, INC. | $58.84 | 2019 | |
| Astellas Pharma US INC | $48.25 | 2019 | |
| Merck Sharp & Dohme LLC | $48.04 | 2019 | |
| Glaxosmithkline, LLC. | $44.69 | 2019 | |
| Janssen Pharmaceuticals, INC | $37.56 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $35.37 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $24.18 | 2019 | |
| Ibsa Pharma INC. | $20.09 | 2019 | |
| Amarin Pharma, INC. | $19.16 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $18.84 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kowa Pharmaceuticals America, INC. | $13.92 | 2019 | |
| Circassia INC. | $13.37 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $12.94 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $12.34 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $12.19 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $12.14 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lisa Affatato-Bradley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.